| scholarly article | Q13442814 |
| P2093 | author name string | Crawford JM | |
| Martin TR | |||
| Kobzik L | |||
| Ferrara JL | |||
| Brewer JP | |||
| Hill GR | |||
| Cooke KR | |||
| Gerbitz A | |||
| P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| pneumonia | Q12192 | ||
| donor cell | Q107637879 | ||
| lipopolysaccharide | Q421804 | ||
| Idiopathic pneumonia syndrome | Q5988895 | ||
| P304 | page(s) | 6612-6619 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation. | |
| P478 | volume | 165 |
| Q36665735 | A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome |
| Q34979948 | Accumulation of CD4+ T cells in the colon of CsA-treated mice following myeloablative conditioning and bone marrow transplantation |
| Q35694784 | An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome |
| Q33944262 | Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses |
| Q59094154 | Chronic Graft-Versus-Host Disease in Children |
| Q55092065 | Correlation of Severity of Functional Gastrointestinal Disease Symptoms with that of Asthma and Chronic Obstructive Pulmonary Disease: A Multicenter Study. |
| Q40218877 | Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: implications for lung cancer screening |
| Q36328397 | Evaluation of pulmonary infiltrates in patients after stem cell transplantation |
| Q35231183 | Gut flora enhance bacterial clearance in lung through toll-like receptors 4 |
| Q36174406 | Gut-lung axis: The microbial contributions and clinical implications |
| Q40491294 | Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production |
| Q35717842 | Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia. |
| Q33781213 | Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation |
| Q38739840 | Lung-gut cross-talk: evidence, mechanisms and implications for the mucosal inflammatory diseases. |
| Q27001015 | Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
| Q35525708 | Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice |
| Q34962952 | Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease. |
| Q34027424 | Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical tri |
| Q39187660 | Role of the microbiome in swine respiratory disease |
| Q37338471 | Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation |
| Q34858453 | TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521). |
| Q42847955 | The Protective Role of Host Toll-Like Receptor-4 in Acute Graft-Versus-Host Disease |
| Q34607576 | The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation |
Search more.